|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 98, 928-934, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
A Kawaguchi, I Gandjbakhch, A Pavie, C Muneretto, V Bors, P Leger, A Cabrol, M Desruennes and C Cabrol
In an attempt to identify the factors that influence survival after
heterotopic heart transplantation, 42 consecutive recipients of heterotopic
heart transplant were reviewed. Preoperative pulmonary artery pressures,
pulmonary vascular resistance, and donor age significantly differed between
hospital survivors and nonsurvivors. Postoperative survival analysis
between pairs of groups of patients divided by each of these variables
disclosed a significant difference, which confirmed the effects of these
variables on survival. Evolution of pulmonary hemodynamics was compared
between patients with preoperative pulmonary artery diastolic pressure
greater than 25 mm Hg (pulmonary hypertension; n = 22) or less than 25 mm
Hg (nonpulmonary hypertension; n = 20). Despite marked differences in
preoperative pulmonary hemodynamics, pulmonary artery pressures were
dramatically reduced immediately after transplantation, and pulmonary
vascular resistance diminished to upper normal limits at 10 days when there
were no longer differences in pulmonary vascular resistance between the two
groups. Immediate deaths were related to left ventricular failure, and the
incidence was similar between the groups. Despite such normalization of
pulmonary hemodynamics, patients with preoperative pulmonary hypertension
experienced more frequent ventricular fibrillation, required longer
respiratory support, and developed lethal pulmonary or systemic infection,
which resulted in a 32% (7/22) hospital survival rate compared with 90%
(18/20) in patients without pulmonary hypertension. Despite the dramatic
improvement in pulmonary hemodynamics, heterotopic heart failed to
demonstrate the expected advantages because of frequent pulmonary
complications and infection, which resulted in failure to improve the
prognosis of patients with preoperative pulmonary hypertension.
ARTICLES
Factors affecting survival after heterotopic heart transplantation
Service de Chirurgie Cardiovasculaire Hopital de la Pitie, Paris, France.
This article has been cited by other articles:
![]() |
A. Al-Khaldi, B. A. Reitz, H. Zhu, and D. Rosenthal Heterotopic Heart Transplant Combined With Postoperative Sildenafil Use for the Treatment of Restrictive Cardiomyopathy Ann. Thorac. Surg., April 1, 2006; 81(4): 1505 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khaghani, F. Santini, C. M. Dyke, O. Onuzu, R. Radley-Smith, and M. H. Yacoub HETEROTOPIC CARDIAC TRANSPLANTATION IN INFANTS AND CHILDREN J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1042 - 1049. [Abstract] [Full Text] |
||||
![]() |
L. Martinelli, M. Rinaldi, C. Pederzolli, C. Goggi, N. Pederzolli, and M. Vigano' Successful Treatment of Aortic Dissection After Heterotopic Heart Transplantation Ann. Thorac. Surg., April 1, 1995; 59(4): 990 - 992. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |